TANG CAPITAL PARTNERS LP 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-26 4:00 pm Sale | 2023-12-26 | 13G | RENEO PHARMACEUTICALS INC RPHM | TANG CAPITAL PARTNERS LP | 294,626 8.800% | -38,374 (-11.52%) | Filing |
| 2023-12-26 5:00 pm Purchase | 2023-11-14 | 13D | RENEO PHARMACEUTICALS INC RPHM | TANG CAPITAL PARTNERS LP | 333,000 9.996% | 333,000 (New Position) | Filing |